Deirdre Weymann - School of Population and Public Health, University of British Columbia

基本信息

Career Trajectory

Bio

Deirdre Weymann is a Senior Health Economist at BC Cancer whose work focuses on quasi-experimental methods for economic evaluation in precision medicine. Her research interests include health economics, healthcare policy and applied econometrics.

Research Interests

Papers共 59 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity

Hadley Stevens Smith,James Buchanan,Ilias Goranitis, Maarten J IJzerman,Tara A Lavelle, Deborah A Marshall, Dean A Regier,Wendy J Ungar,Deirdre Weymann,Sarah Wordsworth,Kathryn A Phillips, Jeroen P Jansen

Value in health the journal of the International Society for Pharmacoeconomics and Outcomes Research (2025)

Cited0Views0WOSBibtex

Adopting Life-Cycle HTA: A Tumour-Agnostic Precision Oncology Index Economic Evaluation from Publicly-Available Reimbursement Reviews

Gemma Cupples,Emanuel Krebs,Deirdre Weymann,Cheryl Ho, Dean A Regier

International journal of technology assessment in health carepp.1-31, (2025)

Cited0Views0WOSBibtex

The Health Economics of Genomic Technologies: A Growing Evidence Base on Value

James Buchanan,Ilias Goranitis,Deirdre Weymann

Applied Health Economics and Health Policyno. 3 (2025): 331-335

Cited0Views0WOSBibtex

Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation

Emanuel Krebs,Deirdre Weymann,Cheryl Ho,Alison Weppler,Ian Bosdet,Aly Karsan,Timothy P Hanna,Samantha Pollard,Dean A Regier

JCO precision oncology (2025): e2400294-e2400294

Cited0Views0WOSBibtex

EE566 Real-World Evidence of Multi-Gene Panel Sequencing Effectiveness and Cost-Effectiveness for Advanced Cancers: A Tumor-Agnostic Target Trial Emulation

E Krebs,D Weymann, D Regier

Value in Health（2024）

Cited0Views0Bibtex

Health Care Costs after Genome-Wide Sequencing for Children with Rare Diseases in England and Canada

Deirdre Weymann,John Buckell,Patrick Fahr,Rosalie Loewen,Morgan Ehman,Samantha Pollard,Jan M. Friedman,Sylvia Stockler-Ipsiroglu,Alison M. Elliott,Sarah Wordsworth,James Buchanan,Dean A. Regier

JAMA NETWORK OPENno. 7 (2024)

Cited0Views0WOSBibtex

87P Application of Tissue and Liquid-Based Next Generation Sequencing (NGS) for Comprehensive Genomic Profiling: Evaluating the Clinical Value of Ctdna Technology in Treatment Decision Making

F.U. Usman, S.Y. Sabag, E. Bhang, M. Kamali,S. Pollard, A. Hussein, J. Ko-Leong,C. Hughesman,D. Alex, P. Demarco,D. Weymann,J.M. Loree, K. Gill, Y. Wang,J. Laskin, D. Regier,H. Lim,S. Chia,S. Yip,C. Ho

Annals of Oncology (2024): S249

Cited0Views0Bibtex

HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: an Interrupted Time Series Analysis

D. Weymann, E. Krebs,S. Pollard,I Bosdet,S. Yip,A. Karsan,C. Ho,H. Lim,J. M. Loree,J. Laskin, M. Law,D. A. Regier

Value in Healthno. 6 (2024): S216-S217

Cited0Views0Bibtex

Next-generation Sequencing in Oncology: Challenges in Economic Evaluations

Morgan Ehman, Jesman Punian,Deirdre Weymann,Dean A Regier

Expert review of pharmacoeconomics & outcomes researchno. 10 (2024): 1115-1132

Cited1Views0WOSBibtex

HTA356 Operationalizing Life-Cycle HTA: A Tumor-Agnostic Precision Oncology Index Economic Evaluation from Canada

G Cupples, E Krebs,D Weymann, D Regier

Value in Healthno. 12 (2024): S426

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn